Additional Amount repayment of loan.

No definition available.

Name:	sedo_AdditionalAmountRepaymentOfLoan
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Debt interest and financial expenses.

+ References

No definition available.

+ Details

Name:	sedo_DebtInterestAndFinancialExpenses
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Description of amendments.

+ References

No definition available.

+ Details

Name:	sedo_DescriptionOfAmendments
Namespace Prefix:	sedo_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The gain (loss) cash flow effect of changes in fair value of warrants.

+ References

No definition available.

+ Details

Name:	sedo_GainLossOnFairValueOfWarrants
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Investment amount for joint venture and production.

+ References

No definition available.

+ Details

Name:	sedo_InvestmentAmountForJointVentureAndProduction
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage of additional coversion of loan of revenues.

+ References

No definition available.

+ Details

Name:	sedo_PercentageOfAdditionalCoversionOfLoanOfRevenues
Namespace Prefix:	sedo_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of conversion of loan of revenues.

+ References

No definition available.

+ Details

Name:	sedo_PercentageOfConversionOfLoanOfRevenues
Namespace Prefix:	sedo_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of shares outstanding.

+ References

No definition available.

+ Details

Name:	sedo_PercentageOfSharesOutstanding
Namespace Prefix:	sedo_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Ryalties paid maximum

+ References

No definition available.

+ Details

Name:	sedo_RyaltiesPaidMaximum
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Ryalties paid minimum

+ References

No definition available.

+ Details

Name:	sedo_RyaltiesPaidMinimum
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fair value of warrants.

+ References

No definition available.

+ Details

Name:	sedo_WarrantsFairValue
Namespace Prefix:	sedo_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Face amount or stated value per share of common stock.

+ References

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

+ Details

Name:	us-gaap_DebtConversionConvertedInstrumentSharesIssued1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

+ Details

Name:	us-gaap_DebtConversionOriginalDebtAmount1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

+ Details

Name:	us-gaap_DebtInstrumentFaceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Contractual interest rate for funds borrowed, under the debt agreement.

+ References

+ Details

Name:	us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of unrealized and realized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity), investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).

+ References

No definition available.

+ Details

Name:	us-gaap_DebtSecuritiesGainLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(3),(4))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_DueToRelatedPartiesCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of cash paid for royalties during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

+ Details

Name:	us-gaap_PaymentsForRoyalties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromConvertibleDebt
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_RelatedPartyCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sedo_CannabicsPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=sedo_SecondInvestmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=sedo_ConvertibleLoanAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sedo_ErollGrowTechMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=sedo_TrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=sedo_TrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=sedo_TrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

RELATED PARTIES (Details) - USD ($) $ / shares in Units, $ in Thousands								1 Months Ended		3 Months Ended		12 Months Ended
	Mar. 05, 2019	Jan. 15, 2019	Dec. 10, 2018	Nov. 06, 2018	Sep. 14, 2018	Sep. 12, 2018	Sep. 12, 2018	Oct. 23, 2018	Sep. 27, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Sep. 07, 2018	Aug. 14, 2018	Aug. 13, 2018	Aug. 10, 2018
Interest rate										17.50%
Loan term										180 days
Debt conversion, shares issued	500,000	770,397						250,000
Par value	$ 0.0001	$ 0.0001						$ 0.0001		$ 0.0001		$ 0.0001
Gross proceeds from convertible loan										$ 250
Other accounts payable to related party										623		$ 520
General and administrative expenses to related party										103		24
Loss from changes in fair value of warrants										1
Debt interest and financial expenses										17
Converted loan amount	$ 500	$ 1,000								162
Cannabics Pharmaceuticals Inc. [Member]
Debt amount													$ 350
Percentage of shares outstanding													3.60%
Shares issued									540,000
Description of Amendments						Cannabics Pharmaceuticals Inc. shall receive 10% (5% issued on the date of the money transfer and an additional 5% issued on the date of conversion) of the ordinary shares. On September 26, 2018, pursuant to the Agreement with Cannabics Pharmaceuticals Inc. noted supra, the Company received its 2nd installment of $500.
Par value									$ 0.0001
Cannabics Pharmaceuticals Inc. [Member] \| Warrant [Member]
Purchase warrants														1,000,000
Exercise price														$ 2.00
Fair value of warrants										$ 0		$ 1
Percentage of shares outstanding										10.00%
Shares issued							1,000
Cannabics Pharmaceuticals Inc. [Member] \| Second Investment [Member] \| Warrant [Member]
Percentage of shares outstanding										5.00%
Convertible Loan Agreement [Member] \| Eroll Grow Tech [Member]
Investment amount															$ 500	$ 2,000
Convertible Loan Agreement [Member] \| Cannabics Pharmaceuticals Inc. [Member]
Debt amount										$ 250
Debt conversion, shares issued		770,397
Percentage of shares outstanding		20.43%													7.50%
Par value		$ 0.0001
Gross proceeds from convertible loan			$ 700	$ 300						250
Loss on convertiable loan										$ 500
Additional Amount repayment of loan									$ 1,000
Percentage of additional coversion of loan of revenues									2.50%
Percentage of conversion of loan of revenues									5.00%
Ryalties paid minimum									$ 500
Ryalties paid maximum									$ 8,000
Provision for royalties					$ 500
Debt interest and financial expenses		$ 942
Converted loan amount		$ 1,000
Convertible Loan Agreement [Member] \| Cannabics Pharmaceuticals Inc. [Member] \| Tranche One [Member]
Investment amount																500
Convertible Loan Agreement [Member] \| Cannabics Pharmaceuticals Inc. [Member] \| Tranche Two [Member]
Investment amount																500
Convertible Loan Agreement [Member] \| Cannabics Pharmaceuticals Inc. [Member] \| Tranche Three [Member]
Investment amount																$ 1,000
Convertible Loan Agreement [Member] \| Cannabics Pharmaceuticals Inc. [Member] \| Second Investment [Member]
Percentage of shares outstanding															15.00%